{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,26]],"date-time":"2026-10-26T23:55:24Z","timestamp":1793058924029,"version":"4.5.0"},"reference-count":52,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2016,5,25]],"date-time":"2016-05-25T00:00:00Z","timestamp":1464134400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Leukemia"],"published-print":{"date-parts":[[2016,8]]},"DOI":"10.1038\/leu.2016.79","type":"journal-article","created":{"date-parts":[[2016,4,25]],"date-time":"2016-04-25T02:41:41Z","timestamp":1461552101000},"page":"1691-1700","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":53,"title":["Long-term in vitro maintenance of clonal abundance and leukaemia-initiating potential in acute lymphoblastic leukaemia"],"prefix":"10.1038","volume":"30","author":[{"given":"D","family":"Pal","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H J","family":"Blair","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A","family":"Elder","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K","family":"Dormon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K J","family":"Rennie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D J L","family":"Coleman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J","family":"Weiland","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K S","family":"Rankin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A","family":"Filby","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5404-6483","authenticated-orcid":false,"given":"O","family":"Heidenreich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J","family":"Vormoor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2016,5,25]]},"reference":[{"key":"BFleu201679_CR1","doi-asserted-by":"publisher","first-page":"586","DOI":"10.1038\/leu.2012.276","volume":"27","author":"MR Janes","year":"2013","unstructured":"Janes MR, Vu C, Mallya S, Shieh MP, Limon JJ, Li LS et al. Efficacy of the investigational mTOR kinase inhibitor MLN0128\/INK128 in models of B-cell acute lymphoblastic leukemia. Leukemia 2013; 27: 586\u2013594.","journal-title":"Leukemia"},{"key":"BFleu201679_CR2","doi-asserted-by":"publisher","first-page":"2843","DOI":"10.1182\/blood-2012-02-413021","volume":"120","author":"CJ Ott","year":"2012","unstructured":"Ott CJ, Kopp N, Bird L, Paranal RM, Qi J, Bowman T et al. BET bromodomain inhibition targets both c-Myc and IL7R in high-risk acute lymphoblastic leukemia. Blood 2012; 120: 2843\u20132852.","journal-title":"Blood"},{"key":"BFleu201679_CR3","doi-asserted-by":"publisher","first-page":"1386","DOI":"10.1038\/ng.2777","volume":"45","author":"JD Jaffe","year":"2013","unstructured":"Jaffe JD, Wang Y, Chan HM, Zhang J, Huether R, Kryukov GV et al. Global chromatin profiling reveals NSD2 mutations in pediatric acute lymphoblastic leukemia. Nat Genet 2013; 45: 1386\u20131391.","journal-title":"Nat Genet"},{"key":"BFleu201679_CR4","doi-asserted-by":"publisher","first-page":"1165","DOI":"10.1182\/blood-2012-06-438002","volume":"121","author":"W Haso","year":"2013","unstructured":"Haso W, Lee DW, Shah NN, Stetler-Stevenson M, Yuan CM, Pastan IH et al. Anti-CD22-chimeric antigen receptors targeting B-cell precursor acute lymphoblastic leukemia. Blood 2013; 121: 1165\u20131174.","journal-title":"Blood"},{"key":"BFleu201679_CR5","doi-asserted-by":"publisher","first-page":"1445","DOI":"10.1158\/1078-0432.CCR-12-1511","volume":"19","author":"L Bastian","year":"2013","unstructured":"Bastian L, Hof J, Pfau M, Fichtner I, Eckert C, Henze G et al. Synergistic activity of bortezomib and HDACi in preclinical models of B-cell precursor acute lymphoblastic leukemia via modulation of p53, PI3K\/AKT, and NF-kappaB. Clin Cancer Res 2013; 19: 1445\u20131457.","journal-title":"Clin Cancer Res"},{"key":"BFleu201679_CR6","doi-asserted-by":"publisher","first-page":"554","DOI":"10.1038\/leu.2013.361","volume":"28","author":"M Scherr","year":"2014","unstructured":"Scherr M, Elder A, Battmer K, Barzan D, Bomken S, Ricke-Hoch M et al. Differential expression of miR-17~92 identifies BCL2 as a therapeutic target in BCR-ABL-positive B-lineage acute lymphoblastic leukemia. Leukemia 2014; 28: 554\u2013565.","journal-title":"Leukemia"},{"key":"BFleu201679_CR7","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1038\/483531a","volume":"483","author":"CG Begley","year":"2012","unstructured":"Begley CG, Ellis LM . Drug development: raise standards for preclinical cancer research. Nature 2012; 483: 531\u2013533.","journal-title":"Nature"},{"key":"BFleu201679_CR8","doi-asserted-by":"publisher","first-page":"5160","DOI":"10.1158\/1078-0432.CCR-12-2408","volume":"18","author":"S Kopetz","year":"2012","unstructured":"Kopetz S, Lemos R, Powis G . The promise of patient-derived xenografts: the best laid plans of mice and men. Clin Cancer Res 2012; 18: 5160\u20135162.","journal-title":"Clin Cancer Res"},{"key":"BFleu201679_CR9","doi-asserted-by":"publisher","first-page":"452","DOI":"10.1093\/jnci\/djt007","volume":"105","author":"JP Gillet","year":"2013","unstructured":"Gillet JP, Varma S, Gottesman MM . The clinical relevance of cancer cell lines. J Natl Cancer Inst 2013; 105: 452\u2013458.","journal-title":"J Natl Cancer Inst"},{"key":"BFleu201679_CR10","doi-asserted-by":"publisher","first-page":"11501","DOI":"10.18632\/oncotarget.2572","volume":"5","author":"J Boutter","year":"2014","unstructured":"Boutter J, Huang Y, Marovca B, Vonderheit A, Grotzer MA, Eckert C et al. Image-based RNA interference screening reveals an individual dependence of acute lymphoblastic leukemia on stromal cysteine support. Oncotarget 2014; 5: 11501\u201311512.","journal-title":"Oncotarget"},{"key":"BFleu201679_CR11","doi-asserted-by":"crossref","first-page":"2370","DOI":"10.1182\/blood.V79.9.2370.2370","volume":"79","author":"A Manabe","year":"1992","unstructured":"Manabe A, Coustan-Smith E, Behm FG, Raimondi SC, Campana D . Bone marrow-derived stromal cells prevent apoptotic cell death in B-lineage acute lymphoblastic leukemia. Blood 1992; 79: 2370\u20132377.","journal-title":"Blood"},{"key":"BFleu201679_CR12","doi-asserted-by":"publisher","first-page":"846","DOI":"10.1046\/j.1365-2141.2003.04217.x","volume":"120","author":"K Mihara","year":"2003","unstructured":"Mihara K, Imai C, Coustan-Smith E, Dome JS, Dominici M, Vanin E et al. Development and functional characterization of human bone marrow mesenchymal cells immortalized by enforced expression of telomerase. Br J Haematol 2003; 120: 846\u2013849.","journal-title":"Br J Haematol"},{"key":"BFleu201679_CR13","doi-asserted-by":"publisher","first-page":"3262","DOI":"10.1200\/JCO.2003.11.031","volume":"21","author":"ML Den Boer","year":"2003","unstructured":"Den Boer ML, Harms DO, Pieters R, Kazemier KM, Gobel U, Korholz D et al. Patient stratification based on prednisolone-vincristine-asparaginase resistance profiles in children with acute lymphoblastic leukemia. J Clin Oncol 2003; 21: 3262\u20133268.","journal-title":"J Clin Oncol"},{"key":"BFleu201679_CR14","doi-asserted-by":"publisher","first-page":"1597","DOI":"10.1126\/science.2595371","volume":"246","author":"S Kamel-Reid","year":"1989","unstructured":"Kamel-Reid S, Letarte M, Sirard C, Doedens M, Grunberger T, Fulop G et al. A model of human acute lymphoblastic leukemia in immune-deficient SCID mice. Science 1989; 246: 1597\u20131600.","journal-title":"Science"},{"key":"BFleu201679_CR15","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1002\/emmm.201201703","volume":"5","author":"K Rehe","year":"2013","unstructured":"Rehe K, Wilson K, Bomken S, Williamson D, Irving J, den Boer ML et al. Acute B lymphoblastic leukaemia-propagating cells are present at high frequency in diverse lymphoblast populations. EMBO Mol Med 2013; 5: 38\u201351.","journal-title":"EMBO Mol Med"},{"key":"BFleu201679_CR16","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1016\/j.ccr.2008.05.015","volume":"14","author":"C le Viseur","year":"2008","unstructured":"le Viseur C, Hotfilder M, Bomken S, Wilson K, Rottgers S, Schrauder A et al. In childhood acute lymphoblastic leukemia, blasts at different stages of immunophenotypic maturation have stem cell properties. Cancer Cell 2008; 14: 47\u201358.","journal-title":"Cancer Cell"},{"key":"BFleu201679_CR17","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1182\/blood-2014-01-549352","volume":"124","author":"B Patel","year":"2014","unstructured":"Patel B, Dey A, Castleton AZ, Schwab C, Samuel E, Sivakumaran J et al. Mouse xenograft modeling of human adult acute lymphoblastic leukemia provides mechanistic insights into adult LIC biology. Blood 2014; 124: 96\u2013105.","journal-title":"Blood"},{"key":"BFleu201679_CR18","doi-asserted-by":"publisher","first-page":"1854","DOI":"10.1182\/blood-2010-11-320309","volume":"118","author":"M Schmitz","year":"2011","unstructured":"Schmitz M, Breithaupt P, Scheidegger N, Cario G, Bonapace L, Meissner B et al. Xenografts of highly resistant leukemia recapitulate the clonal composition of the leukemogenic compartment. Blood 2011; 118: 1854\u20131864.","journal-title":"Blood"},{"key":"BFleu201679_CR19","doi-asserted-by":"publisher","first-page":"362","DOI":"10.1038\/nature09733","volume":"469","author":"F Notta","year":"2011","unstructured":"Notta F, Mullighan CG, Wang JC, Poeppl A, Doulatov S, Phillips LA et al. Evolution of human BCR-ABL1 lymphoblastic leukaemia-initiating cells. Nature 2011; 469: 362\u2013367.","journal-title":"Nature"},{"key":"BFleu201679_CR20","doi-asserted-by":"publisher","first-page":"653","DOI":"10.1084\/jem.20110105","volume":"208","author":"E Clappier","year":"2011","unstructured":"Clappier E, Gerby B, Sigaux F, Delord M, Touzri F, Hernandez L et al. Clonal selection in xenografted human T cell acute lymphoblastic leukemia recapitulates gain of malignancy at relapse. J Exp Med 2011; 208: 653\u2013661.","journal-title":"J Exp Med"},{"key":"BFleu201679_CR21","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1016\/j.ccr.2012.06.005","volume":"22","author":"KG Roberts","year":"2012","unstructured":"Roberts KG, Morin RD, Zhang J, Hirst M, Zhao Y, Su X et al. Genetic alterations activating kinase and cytokine receptor signaling in high-risk acute lymphoblastic leukemia. Cancer Cell 2012; 22: 153\u2013166.","journal-title":"Cancer Cell"},{"key":"BFleu201679_CR22","doi-asserted-by":"publisher","first-page":"384","DOI":"10.1038\/nature09883","volume":"473","author":"C Duy","year":"2011","unstructured":"Duy C, Hurtz C, Shojaee S, Cerchietti L, Geng H, Swaminathan S et al. BCL6 enables Ph+ acute lymphoblastic leukaemia cells to survive BCR-ABL1 kinase inhibition. Nature 2011; 473: 384\u2013388.","journal-title":"Nature"},{"key":"BFleu201679_CR23","doi-asserted-by":"publisher","first-page":"1005","DOI":"10.1056\/NEJMoa1403088","volume":"371","author":"KG Roberts","year":"2014","unstructured":"Roberts KG, Li Y, Payne-Turner D, Harvey RC, Yang YL, Pei D et al. Targetable kinase-activating lesions in Ph-like acute lymphoblastic leukemia. N Engl J Med 2014; 371: 1005\u20131015.","journal-title":"N Engl J Med"},{"key":"BFleu201679_CR24","doi-asserted-by":"publisher","first-page":"3420","DOI":"10.1182\/blood-2014-04-531871","volume":"124","author":"J Irving","year":"2014","unstructured":"Irving J, Matheson E, Minto L, Blair H, Case M, Halsey C et al. Ras pathway mutations are prevalent in relapsed childhood acute lymphoblastic leukemia and confer sensitivity to MEK inhibition. Blood 2014; 124: 3420\u20133430.","journal-title":"Blood"},{"key":"BFleu201679_CR25","doi-asserted-by":"crossref","first-page":"3735","DOI":"10.1182\/blood.V89.10.3735.3735_3735_3744","volume":"89","author":"H Nishigaki","year":"1997","unstructured":"Nishigaki H, Ito C, Manabe A, Kumagai M, Coustan-Smith E, Yanishevski Y et al. Prevalence and growth characteristics of malignant stem cells in B-lineage acute lymphoblastic leukemia. Blood 1997; 89: 3735\u20133744.","journal-title":"Blood"},{"key":"BFleu201679_CR26","doi-asserted-by":"crossref","first-page":"3324","DOI":"10.4049\/jimmunol.147.10.3324","volume":"147","author":"ML Wolf","year":"1991","unstructured":"Wolf ML, Buckley JA, Goldfarb A, Law CL, LeBien TW . Development of a bone marrow culture for maintenance and growth of normal human B cell precursors. J Immunol 1991; 147: 3324\u20133330.","journal-title":"J Immunol"},{"key":"BFleu201679_CR27","doi-asserted-by":"crossref","first-page":"3817","DOI":"10.1182\/blood.V92.10.3817","volume":"92","author":"N Shah","year":"1998","unstructured":"Shah N, Oseth L, LeBien TW . Development of a model for evaluating the interaction between human pre-B acute lymphoblastic leukemic cells and the bone marrow stromal cell microenvironment. Blood 1998; 92: 3817\u20133828.","journal-title":"Blood"},{"key":"BFleu201679_CR28","first-page":"5268","volume":"61","author":"N Shah","year":"2001","unstructured":"Shah N, Oseth L, Tran H, Hirsch B, LeBien TW . Clonal variation in the B-lineage acute lymphoblastic leukemia response to multiple cytokines and bone marrow stromal cells. Cancer Res 2001; 61: 5268\u20135274.","journal-title":"Cancer Res"},{"key":"BFleu201679_CR29","doi-asserted-by":"crossref","first-page":"3274","DOI":"10.1182\/blood.V79.12.3274.bloodjournal79123274","volume":"79","author":"M Eder","year":"1992","unstructured":"Eder M, Ottmann OG, Hansen-Hagge TE, Bartram CR, Falk S, Gillis S et al. In vitro culture of common acute lymphoblastic leukemia blasts: effects of interleukin-3, interleukin-7, and accessory cells. Blood 1992; 79: 3274\u20133284.","journal-title":"Blood"},{"key":"BFleu201679_CR30","doi-asserted-by":"publisher","first-page":"882","DOI":"10.1038\/sj.leu.2401729","volume":"14","author":"KF Bradstock","year":"2000","unstructured":"Bradstock KF, Makrynikola V, Bianchi A, Shen W, Hewson J, Gottlieb DJ . Effects of the chemokine stromal cell-derived factor-1 on the migration and localization of precursor-B acute lymphoblastic leukemia cells within bone marrow stromal layers. Leukemia 2000; 14: 882\u2013888.","journal-title":"Leukemia"},{"key":"BFleu201679_CR31","doi-asserted-by":"publisher","first-page":"1314","DOI":"10.1038\/leu.2011.76","volume":"25","author":"R Parameswaran","year":"2011","unstructured":"Parameswaran R, Yu M, Lim M, Groffen J, Heisterkamp N . Combination of drug therapy in acute lymphoblastic leukemia with a CXCR4 antagonist. Leukemia 2011; 25: 1314\u20131323.","journal-title":"Leukemia"},{"key":"BFleu201679_CR32","first-page":"1116","volume":"8","author":"M Kumagai","year":"1994","unstructured":"Kumagai M, Manabe A, Coustan-Smith E, Blakley RL, Beck WT, Santana VM et al. Use of stroma-supported cultures of leukemic cells to assess antileukemic drugs. II. Potent cytotoxicity of 2-chloro-deoxyadenosine in acute lymphoblastic leukemia. Leukemia 1994; 8: 1116\u20131123.","journal-title":"Leukemia"},{"key":"BFleu201679_CR33","doi-asserted-by":"publisher","first-page":"378","DOI":"10.3109\/10428194.2013.793323","volume":"55","author":"OS Aljitawi","year":"2014","unstructured":"Aljitawi OS, Li D, Xiao Y, Zhang D, Ramachandran K, Stehno-Bittel L et al. A novel three-dimensional stromal-based model for in vitro chemotherapy sensitivity testing of leukemia cells. Leuk Lymphoma 2014; 55: 378\u2013391.","journal-title":"Leuk Lymphoma"},{"key":"BFleu201679_CR34","doi-asserted-by":"publisher","first-page":"520","DOI":"10.5966\/sctm.2013-0166","volume":"3","author":"E Griessinger","year":"2014","unstructured":"Griessinger E, Anjos-Afonso F, Pizzitola I, Rouault-Pierre K, Vargaftig J, Taussig D et al. A niche-like culture system allowing the maintenance of primary human acute myeloid leukemia-initiating cells: a new tool to decipher their chemoresistance and self-renewal mechanisms. Stem Cells Transl Med 2014; 3: 520\u2013529.","journal-title":"Stem Cells Transl Med"},{"key":"BFleu201679_CR35","first-page":"813","volume":"10","author":"K Bradstock","year":"1996","unstructured":"Bradstock K, Bianchi A, Makrynikola V, Filshie R, Gottlieb D . Long-term survival and proliferation of precursor-B acute lymphoblastic leukemia cells on human bone marrow stroma. Leukemia 1996; 10: 813\u2013820.","journal-title":"Leukemia"},{"key":"BFleu201679_CR36","doi-asserted-by":"publisher","first-page":"718","DOI":"10.1038\/leu.2012.206","volume":"27","author":"S Bomken","year":"2013","unstructured":"Bomken S, Buechler L, Rehe K, Ponthan F, Elder A, Blair H et al. Lentiviral marking of patient-derived acute lymphoblastic leukaemic cells allows in vivo tracking of disease progression. Leukemia 2013; 27: 718\u2013721.","journal-title":"Leukemia"},{"key":"BFleu201679_CR37","doi-asserted-by":"publisher","first-page":"440","DOI":"10.1158\/0008-5472.CAN-09-1947","volume":"70","author":"TC Chou","year":"2010","unstructured":"Chou TC . Drug combination studies and their synergy quantification using the Chou-Talalay method. Cancer Res 2010; 70: 440\u2013446.","journal-title":"Cancer Res"},{"key":"BFleu201679_CR38","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1186\/1423-0127-17-64","volume":"17","author":"CC Tsai","year":"2010","unstructured":"Tsai CC, Chen CL, Liu HC, Lee YT, Wang HW, Hou LT et al. Overexpression of hTERT increases stem-like properties and decreases spontaneous differentiation in human mesenchymal stem cell lines. J Biomed Sci 2010; 17: 64.","journal-title":"J Biomed Sci"},{"key":"BFleu201679_CR39","first-page":"1592","volume":"7","author":"E Ishii","year":"1993","unstructured":"Ishii E, Greaves A, Grunberger T, Freedman MH, Letarte M . The induction of CD10 on a pre-B leukemia cell line occurs with progression of the disease in scid mice. Leukemia 1993; 7: 1592\u20131601.","journal-title":"Leukemia"},{"key":"BFleu201679_CR40","first-page":"8","volume":"6","author":"S Kamel-Reid","year":"1992","unstructured":"Kamel-Reid S, Dick JE, Greaves A, Murdoch B, Doedens M, Grunberger T et al. Differential kinetics of engraftment and induction of CD10 on human pre-B leukemia cell lines in immune deficient scid mice. Leukemia 1992; 6: 8\u201317.","journal-title":"Leukemia"},{"key":"BFleu201679_CR41","doi-asserted-by":"publisher","first-page":"2610","DOI":"10.1182\/blood-2009-06-229757","volume":"115","author":"A Gerrits","year":"2010","unstructured":"Gerrits A, Dykstra B, Kalmykowa OJ, Klauke K, Verovskaya E, Broekhuis MJ et al. Cellular barcoding tool for clonal analysis in the hematopoietic system. Blood 2010; 115: 2610\u20132618.","journal-title":"Blood"},{"key":"BFleu201679_CR42","doi-asserted-by":"publisher","first-page":"440","DOI":"10.1038\/nm.3841","volume":"21","author":"HE Bhang","year":"2015","unstructured":"Bhang HE, Ruddy DA, Krishnamurthy Radhakrishna V, Caushi JX, Zhao R, Hims MM et al. Studying clonal dynamics in response to cancer therapy using high-complexity barcoding. Nat Med 2015; 21: 440\u2013448.","journal-title":"Nat Med"},{"key":"BFleu201679_CR43","doi-asserted-by":"publisher","first-page":"A1","DOI":"10.1055\/s-0032-1310468","volume":"224","author":"AK Elder","year":"2012","unstructured":"Elder AK, Heidenreich O, Vormoor HJ . Lentiviralmarking as a tool to investigate the clonal complexity and evolution of ALL. Klin Padiatr 2012; 224: A1.","journal-title":"Klin Padiatr"},{"key":"BFleu201679_CR44","doi-asserted-by":"publisher","first-page":"1020","DOI":"10.1038\/ng.3362","volume":"47","author":"U Fischer","year":"2015","unstructured":"Fischer U, Forster M, Rinaldi A, Risch T, Sungalee S, Warnatz HJ et al. Genomics and drug profiling of fatal TCF3-HLF-positive acute lymphoblastic leukemia identifies recurrent mutation patterns and therapeutic options. Nat Gen 2015; 47: 1020\u20131029.","journal-title":"Nat Gen"},{"key":"BFleu201679_CR45","doi-asserted-by":"publisher","first-page":"2715","DOI":"10.1016\/j.celrep.2015.12.003","volume":"13","author":"JM Benito","year":"2015","unstructured":"Benito JM, Godfrey L, Kojima K, Hogdal L, Wunderlich M, Geng H et al. MLL-rearranged acute lymphoblastic leukemias activate BCL-2 through H3K79 methylation and are sensitive to the BCL-2-specific antagonist ABT-199. Cell Rep 2015; 13: 2715\u20132727.","journal-title":"Cell Rep"},{"key":"BFleu201679_CR46","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1038\/nm.3048","volume":"19","author":"AJ Souers","year":"2013","unstructured":"Souers AJ, Leverson JD, Boghaert ER, Ackler SL, Catron ND, Chen J et al. ABT-199, a potent and selective BCL-2 inhibitor, achieves antitumor activity while sparing platelets. Nat Med 2013; 19: 202\u2013208.","journal-title":"Nat Med"},{"key":"BFleu201679_CR47","doi-asserted-by":"publisher","first-page":"637","DOI":"10.1038\/nature12612","volume":"502","author":"Y Kunisaki","year":"2013","unstructured":"Kunisaki Y, Bruns I, Scheiermann C, Ahmed J, Pinho S, Zhang D et al. Arteriolar niches maintain haematopoietic stem cell quiescence. Nature 2013; 502: 637\u2013643.","journal-title":"Nature"},{"key":"BFleu201679_CR48","doi-asserted-by":"publisher","first-page":"778","DOI":"10.1016\/j.ccr.2014.04.015","volume":"25","author":"CW Duan","year":"2014","unstructured":"Duan CW, Shi J, Chen J, Wang B, Yu YH, Qin X et al. Leukemia propagating cells rebuild an evolving niche in response to therapy. Cancer Cell 2014; 25: 778\u2013793.","journal-title":"Cancer Cell"},{"key":"BFleu201679_CR49","doi-asserted-by":"publisher","first-page":"829","DOI":"10.1038\/nature09262","volume":"466","author":"S Mendez-Ferrer","year":"2010","unstructured":"Mendez-Ferrer S, Michurina TV, Ferraro F, Mazloom AR, Macarthur BD, Lira SA et al. Mesenchymal and haematopoietic stem cells form a unique bone marrow niche. Nature 2010; 466: 829\u2013834.","journal-title":"Nature"},{"key":"BFleu201679_CR50","doi-asserted-by":"publisher","first-page":"902","DOI":"10.1182\/blood-2010-01-262691","volume":"117","author":"S Pillozzi","year":"2011","unstructured":"Pillozzi S, Masselli M, De Lorenzo E, Accordi B, Cilia E, Crociani O et al. Chemotherapy resistance in acute lymphoblastic leukemia requires hERG1 channels and is overcome by hERG1 blockers. Blood 2011; 117: 902\u2013914.","journal-title":"Blood"},{"key":"BFleu201679_CR51","doi-asserted-by":"publisher","first-page":"2404","DOI":"10.1182\/blood-2015-03-634238","volume":"126","author":"R Polak","year":"2015","unstructured":"Polak R, de Rooij B, Pieters R, den Boer ML . B-cell precursor acute lymphoblastic leukemia cells use tunneling nanotubes to orchestrate their microenvironment. Blood 2015; 126: 2404\u20132414.","journal-title":"Blood"},{"key":"BFleu201679_CR52","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1186\/1479-5876-5-2","volume":"5","author":"EF Velazquez","year":"2007","unstructured":"Velazquez EF, Yancovitz M, Pavlick A, Berman R, Shapiro R, Bogunovic D et al. Clinical relevance of neutral endopeptidase (NEP\/CD10) in melanoma. J Transl Med 2007; 5: 2.","journal-title":"J Transl Med"}],"container-title":["Leukemia"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/leu201679.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/leu201679","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/leu201679.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,17]],"date-time":"2023-08-17T15:23:55Z","timestamp":1692285835000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/leu201679"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,5,25]]},"references-count":52,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2016,8]]}},"alternative-id":["BFleu201679"],"URL":"https:\/\/doi.org\/10.1038\/leu.2016.79","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.726310694.793523634","asserted-by":"object"}]},"ISSN":["0887-6924","1476-5551"],"issn-type":[{"value":"0887-6924","type":"print"},{"value":"1476-5551","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,5,25]]},"assertion":[{"value":"5 August 2015","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 March 2016","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 March 2016","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 May 2016","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no conflict of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}